Menu
Search
|

Menu

Close
X

OraSure Technologies Inc OSUR.OQ (NASDAQ Stock Exchange Global Select Market)

10.77 USD
-0.79 (-6.83%)
As of Mar 22
chart
Previous Close 11.56
Open 11.49
Volume 156,722
3m Avg Volume 193,633
Today’s High 11.55
Today’s Low 10.77
52 Week High 18.44
52 Week Low 9.22
Shares Outstanding (mil) 61.66
Market Capitalization (mil) 664.11
Forward P/E 17.69
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
182
FY17
167
FY16
128
EPS (USD)
FY18
0.609
FY17
0.511
FY16
0.348
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.69
58.10
Price to Sales (TTM)
vs sector
3.65
8.84
Price to Book (MRQ)
vs sector
2.33
4.60
Price to Cash Flow (TTM)
vs sector
14.90
40.07
Total Debt to Equity (MRQ)
vs sector
0.00
17.66
LT Debt to Equity (MRQ)
vs sector
0.00
13.97
Return on Investment (TTM)
vs sector
13.82
12.12
Return on Equity (TTM)
vs sector
14.08
13.24

EXECUTIVE LEADERSHIP

Stephen Tang
Chairman of the Board, President, Chief Executive Officer, Since 2018
Salary: --
Bonus: --
Brian Smith
Vice Chairman of the Board, Executive Vice President - Innovation, Since 2019
Salary: $259,778.00
Bonus: $317,639.00
Roberto Cuca
Chief Financial Officer, Principal Accounting Officer, Since 2018
Salary: --
Bonus: --
Anthony Zezzo
Executive Vice President, Business Unit Leader, Infectious Disease, Since 2017
Salary: $400,333.00
Bonus: $272,341.00
Michael Reed
Senior Vice President - Research and Development, Chief Scientific Officer, Since 2016
Salary: $211,154.00
Bonus: $128,773.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

150 WEBSTER ST
BETHLEHEM   PA   18015

Phone: +1503.6416115

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

SPONSORED STORIES